Re-priced. Re-proved. Re-focused.

2025 was the year digital health re-priced and re-proved itself.

The easy money era is over, and the ecosystem has emerged from the funding winter more disciplined and selective. Capital is now flowing to teams that can demonstrate adoption, durable economics, and execution at scale. Health systems tightened the rules, demanding workflow fit and measurable ROI, forcing ventures to prove real-world impact—not hype. Evidence and distribution became the new power metrics, separating true operators from storytellers.

As the exits window begins to reopen, the winners are clearer than ever—and so are the consequences for anyone who can’t deliver.

For investors, the report shows how risk has shifted decisively toward venture execution. For pharma leaders, it highlights an ecosystem consolidating around fewer, higher-confidence partners in core categories. For health systems and hospitals, it is a clear signal to seize the momentum for change. And for innovators, it clarifies what the market now values most: evidence, interoperability, and measurable value creation.

Powered by HealthTech Alpha’s billion-plus data points, this report delivers a definitive retrospective on the global digital health ecosystem in 2025 and provides practical guidance for navigating the path forward.

Report Highlights

  • Capital concentrated into ventures with proven performance and real-world impact

  • Deal sizes rose in 2025, signalling stronger investor conviction in high-quality opportunities

  • Health systems increasingly shaped innovation through workflow and ROI requirements

  • Mega-deals continued to dominate, with large rounds accounting for nearly half of all capital deployed

  • M&A activity remained measured as fundraising rebounded and early signs of public-market reopening emerged

Ventures and Companies Covered in the Report

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

Source of Data

Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com

Page Description Content
2-4 Foreword & Key Takeaways
9-19 Hype to Hard Results 8 charts, 3 tables
20-28 Exits & 2026 Outlook 3 charts, 3 tables
29-36 Ecosystem Insights 11 charts, 1 table
37-52 Investment Insights 32 charts, 3 tables
53-60 Cluster Focus 4 charts, 2 tables
61-66 Therapeutic Focus 4 charts, 2 tables
67-84 Regional Snapshots United States (p.69), Europe (p.74), Asia Pacific (p.79); 15 charts, 3 tables
85-88 Key Information

Free

BASIC

  • Download the report headlines
  • Access to limited data in HealthTech Alpha
Free
View
Recommended

PRO

  • Sign up now to download all premium research
  • Access and download all data in HealthTech Alpha
$ 385 /Month
Pro
Custom Solution

Enterprise

  • Get full access to unmatched premium research for your organization
  • Additional collaboration features to take your team's research and collaboration to the next level
Let's Talk
Contact Us

© Galen Growth 2026

Overview

Category

Stage

Total Funding

GGA Score

powered by